GRAFT POLYMER (UK) PLC

Director's Dealing • Jan 8, 2024

National Storage Mechanism | Additional information

RNS Number : 9916Y

Graft Polymer (UK) PLC

08 January 2024

8 January 2024

PDMR Share Dealing

Graft Polymer (UK) Plc ("Company") announces that on 4 January 2024, ordinary shares of £0.001 each in the Company ("Ordinary Shares") were disposed of by a person discharging managerial responsibility ("PDMR") in the Company as listed below.

Name	Role	Nature of transaction	Number of Ordinary Shares
Victor Bolduev	Chief Executive Officer, Director	Transfer of Ordinary Shares	10,750,000

It is further announced that on 4 January 2024, Ordinary Shares were subscribed for (subject to various conditions being met, including approval by the FCA, and publication, of a prospectus ("Conditions")) ("Subscription") by certain PDMRs and persons closely associated with PDMRs as listed below.

Name	Role	Nature of transaction	Number of Ordinary Shares
Victor Bolduev	Chief Executive Officer, Director	Conditional subscription for Ordinary Shares	22,529,1661
Roby Zomer	Chairman, Director	Conditional subscription for Ordinary Shares	11,111,000
Yifat Steuer	Chief Financial Officer, Director	Conditional subscription for Ordinary Shares	11,711,167
Pavel Kobzev	Chief Marketing Officer, Director	Conditional subscription for Ordinary Shares	8,694,0002
Alexander Brooks	Director	Conditional subscription for Ordinary Shares	2,810,667
Anthony Eastman	Company Secretary	Conditional subscription for Ordinary Shares	2,810,6673

1 Of which 11,760,333 Ordinary Shares were subscribed for by Polymer Innovations Inc., a company controlled by Victor Bolduev.

2 Of which 5,675,167 Ordinary Shares were subscribed for by MSW Ltd, a company controlled by Pavel Kobzev.

3 These Ordinary Shares were subscribed for by Tournesol Consulting Ltd, a company controlled by Anthony Eastman.

A further announcement is expected to be made upon the Conditions having been met.

About Graft Polymer

Graft Polymer is a London Stock Exchange listed company (GPL.L) with a cutting-edge, research and development (R&D) and manufacturing facility based in Slovenia which has already introduced more than 50 products to the market. The core business of the Group comprises polymer modification and drug delivery system developments. The Group has developed a proprietary set of polymer modification technologies which uses recycled raw materials and a closed loop system to reduce waste. Graft Polymer's technology can improve existing products and processing methodologies by enhancing performance, simplifying manufacturing, reducing material consumption, widening the choice of feedstocks, and reducing costs.

Graft Polymer has three divisions: polymer modification; IP for Bio/Pharma applications including a drug delivery system (Graft Bio) and the Group's food supplement division. A significant milestone was reached in May 2022 when the Slovenian manufacturing facility was granted a Hazard Analysis and Critical Control Point (HACCP) Certificate. The HACCP Certificate allows it to enter the lucrative Business-to-Consumer market and commercialise its IP for bio/pharma applications, developing active pharmaceutical ingredients and drug delivery platforms for use in the food supplement market, thereby introducing a further revenue stream to its business.

Environment, Social and Governance is at the forefront of the Group's strategy and the facility in Slovenia has been granted ISO 14001 accreditation in recognition of the environmental management systems in place to reduce waste. Graft Polymer only uses REACH and ROHS certificated raw materials instead of toxic raw materials, and its extensive R&D programme has also developed specialised recycling polymer additives which increases the strength of recycled blends and plastic products whilst also reducing plastic waste by between 40 and 50 per cent.

For further information, visit www.graftpolymer.com, follow on Twitter @PolymerLtd or contact:

Graft Polymer (UK) Plc

Roby Zomer, Non-Executive Chairman                                       info@graftpolymer.com

Yifat Steuer, CFO and Executive Director

Notification of dealings in shares by PDMRs of the Company:

1.	Details of PDMR / PDMR Associate
(a)	Name	Victor Bolduev
(b)	Position / status	Chief Executive Officer, Director
(c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(d)	Description of the financial instrument	Ordinary Shares in Graft Polymer (UK) Plc
(e)	Nature of the transaction	Disposal of Ordinary Shares
(f)	Price(s) and volume(s)	Price per Ordinary Share: 0.6 pence Volume: 10,750,000
(g)	Aggregated information Aggregated volume Price	n/a
(h)	Date of the transaction	4 January 2024
(i)	Place of the transaction	London, United Kingdom

1.	Details of PDMR / PDMR Associate
(a)	Name	Victor Bolduev
(b)	Position / status	Chief Executive Officer, Director
(c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(d)	Description of the financial instrument	Ordinary Shares in Graft Polymer (UK) Plc
(e)	Nature of the transaction	Subscription of Ordinary Shares (subject to the Conditions, as defined above, being met)
(f)	Price(s) and volume(s)	Price per Ordinary Share: 0.6 pence Volume: 10,768,833
(g)	Aggregated information Aggregated volume Price	n/a
(h)	Date of the transaction	4 January 2024
(i)	Place of the transaction	London, United Kingdom

1.	Details of PDMR / PDMR Associate
(a)	Name	Polymer Innovations Inc.
(b)	Position / status	Company controlled by Victor Bolduev
(c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(d)	Description of the financial instrument	Ordinary Shares in Graft Polymer (UK) Plc
(e)	Nature of the transaction	Conditional subscription for Ordinary Shares
(f)	Price(s) and volume(s)	Price per Ordinary Share: 0.6 pence Volume: 11,760,333
(g)	Aggregated information Aggregated volume Price	n/a
(h)	Date of the transaction	4 January 2024
(i)	Place of the transaction	London, United Kingdom

1.	Details of PDMR / PDMR Associate
(a)	Name	Roby Zomer
(b)	Position / status	Chairman, Director
(c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(d)	Description of the financial instrument	Ordinary Shares in Graft Polymer (UK) Plc
(e)	Nature of the transaction	Conditional subscription for Ordinary Shares
(f)	Price(s) and volume(s)	Price per Ordinary Share: 0.6 pence Volume: 11,111,000
(g)	Aggregated information Aggregated volume Price	n/a
(h)	Date of the transaction	4 January 2024
(i)	Place of the transaction	London, United Kingdom

1.	Details of PDMR / PDMR Associate
(a)	Name	Yifat Steuer
(b)	Position / status	Chief Financial Officer, Director
(c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(d)	Description of the financial instrument	Ordinary Shares in Graft Polymer (UK) Plc
(e)	Nature of the transaction	Conditional subscription for Ordinary Shares
(f)	Price(s) and volume(s)	Price per Ordinary Share: 0.6 pence Volume: 11,711,167
(g)	Aggregated information Aggregated volume Price	n/a
(h)	Date of the transaction	4 January 2024
(i)	Place of the transaction	London, United Kingdom

1.	Details of PDMR / PDMR Associate
(a)	Name	Pavel Kobzev
(b)	Position / status	Chief Marketing Officer, Director
(c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(d)	Description of the financial instrument	Ordinary Shares in Graft Polymer (UK) Plc
(e)	Nature of the transaction	Conditional subscription for Ordinary Shares
(f)	Price(s) and volume(s)	Price per Ordinary Share: 0.6 pence Volume: 3,018,833
(g)	Aggregated information Aggregated volume Price	n/a
(h)	Date of the transaction	4 January 2024
(i)	Place of the transaction	London, United Kingdom

1.	Details of PDMR / PDMR Associate
(a)	Name	MSW Ltd
(b)	Position / status	Company controlled by Pavel Kobzev
(c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(d)	Description of the financial instrument	Ordinary Shares in Graft Polymer (UK) Plc
(e)	Nature of the transaction	Conditional subscription for Ordinary Shares
(f)	Price(s) and volume(s)	Price per Ordinary Share: 0.6 pence Volume: 5,675,167
(g)	Aggregated information Aggregated volume Price	n/a
(h)	Date of the transaction	4 January 2024
(i)	Place of the transaction	London, United Kingdom

1.	Details of PDMR / PDMR Associate
(a)	Name	Alexander Brooks
(b)	Position / status	Director
(c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(d)	Description of the financial instrument	Ordinary Shares in Graft Polymer (UK) Plc
(e)	Nature of the transaction	Conditional subscription for Ordinary Shares
(f)	Price(s) and volume(s)	Price per Ordinary Share: 0.6 pence Volume: 2,810,667
(g)	Aggregated information Aggregated volume Price	n/a
(h)	Date of the transaction	4 January 2024
(i)	Place of the transaction	London, United Kingdom

1.	Details of PDMR / PDMR Associate
(a)	Name	Tournesol Consulting Ltd
(b)	Position / status	Company controlled by Anthony Eastman
(c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(d)	Description of the financial instrument	Ordinary Shares in Graft Polymer (UK) Plc
(e)	Nature of the transaction	Conditional subscription for Ordinary Shares
(f)	Price(s) and volume(s)	Price per Ordinary Share: 0.6 pence Volume: 2,810,667
(g)	Aggregated information Aggregated volume Price	n/a
(h)	Date of the transaction	4 January 2024
(i)	Place of the transaction	London, United Kingdom

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFFSLSITIIS